<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="664">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04522310</url>
  </required_header>
  <id_info>
    <org_study_id>2020-05</org_study_id>
    <nct_id>NCT04522310</nct_id>
  </id_info>
  <brief_title>ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis</brief_title>
  <acronym>PAMOCOS</acronym>
  <official_title>ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier de Lens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier de Lens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 is a worldwide pandemic. Around 5% of infected patients are admitted in ICU, mainly
      for respiratory failure. Outcome of these patients is linked to other organ failures. Optimal
      therapies are not defined so far. The sponsor want to assess the role of MR-ProADM as
      prognostic biomarker, and the impact of treatments (including supportive treatments) on MOF
      occurrence and outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2020</start_date>
  <completion_date type="Anticipated">October 7, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 7, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association or correlation between MR-ProADM at day 1 and day 3 and the onset of visceral failures extra respiratory in reanimation.</measure>
    <time_frame>comparison to day 1 and day 3</time_frame>
    <description>Association or correlation between MR-ProADM at day 1 and day 3 and the onset of visceral failures extra respiratory in reanimation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality at day 28 and day 90.</measure>
    <time_frame>admission until day 90</time_frame>
    <description>mortality at day 28 and day 90.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between MR-ProADM and mortality at day 28.</measure>
    <time_frame>admission until day 28</time_frame>
    <description>Association between MR-ProADM and mortality at day 28.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association or correlation between patient factor or treatment, and the onset or aggravation of visceral failures (day 3 and day 10), evolution until day 28.</measure>
    <time_frame>admission until day 28</time_frame>
    <description>Association or correlation between patient factor or treatment, and the onset or aggravation of visceral failures (day 3 and day 10), evolution until day 28.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">183</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MR-Pro-ADM</intervention_name>
    <description>Dosage of MR-pro-ADM</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any adult patient admitted in the ICU with COVID-19 pneumonia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any adult patient admitted in the ICU with COVID-19 pneumonia

        Exclusion Criteria:

          -  Pregnancy

          -  Legal reasons (patients under guardianship, curatorship)

          -  Patient's refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicolas VAN GRUNDERBEECK, Dr</last_name>
    <phone>0321696405</phone>
    <phone_ext>+33</phone_ext>
    <email>nvangrunderbeeck@ch-lens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MÃ©lanie VERLAY</last_name>
    <phone>0321691028</phone>
    <phone_ext>+33</phone_ext>
    <email>mverlay@ch-lens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital of Arras</name>
      <address>
        <city>Arras</city>
        <zip>62000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital of Boulogne/mer</name>
      <address>
        <city>Boulogne-sur-Mer</city>
        <zip>62200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>GUILLAUME BRUNIN, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of DOUAI</name>
      <address>
        <city>Douai</city>
        <zip>59507</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>CLAIRE BOULLE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Dunkerque</name>
      <address>
        <city>Dunkerque</city>
        <zip>59240</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>SEBASTIEN BEAGUE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dr Schaffner</name>
      <address>
        <city>Lens</city>
        <zip>62307</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MELANIE VERLAY</last_name>
      <phone>03.21.69.10.28</phone>
      <email>mverlay@ch-lens.fr</email>
    </contact>
    <investigator>
      <last_name>CLEMENT DELPIERRE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Roubaix</name>
      <address>
        <city>Roubaix</city>
        <zip>59100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KATHY DERNIVOIX</last_name>
      <phone>03 20 99 31 31</phone>
      <phone_ext>+33</phone_ext>
      <email>kathy.dernivoix@ch-roubaix.fr</email>
    </contact>
    <investigator>
      <last_name>DELPHINE COLLING, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Tourcoing</name>
      <address>
        <city>Tourcoing</city>
        <zip>59200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>THOMAS CAULIER, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospitalier of Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <zip>59300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>FABIEN LAMBIOTTE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 17, 2020</study_first_submitted>
  <study_first_submitted_qc>August 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2020</study_first_posted>
  <last_update_submitted>August 25, 2020</last_update_submitted>
  <last_update_submitted_qc>August 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Organ Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

